Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daiichi Sankyo
MedTech
Roche nets FDA breakthrough label for AI lung cancer CDx test
Roche’s companion test aims to identify non-small cell lung cancer patients who may benefit from Datroway, from AstraZeneca and Daiichi Sankyo.
Conor Hale
Apr 29, 2025 2:07pm
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Mar 11, 2025 10:24am
J&J vet jumps to Affinia—Chutes & Ladders
Feb 7, 2025 8:30am
Roche companion test moves into HER2-ultralow breast cancer
Feb 4, 2025 12:00pm
Daiichi gins up antibody research collab with German institute
Jan 14, 2025 3:44pm
AstraZeneca, Daiichi share data behind Dato-DXd do-over
Dec 6, 2024 5:21am
